Literature DB >> 15693393

Regulating axon growth within the postnatal central nervous system.

Fenghua Hu1, Stephen M Strittmatter.   

Abstract

As neuronal development enters its final stages, axonal growth is restricted. Recent work indicates that several myelin-derived proteins, Nogo, MAG and OMgp, play a critical role in restricting axonal growth in the mature central nervous system (CNS). These proteins function by binding to an axonal NgR protein that limits axonal growth by activating Rho in neurons. Hypoxic conditions during the later stages of neuronal development have a prominent effect on oligodendrocytes and hence on the expression of these axon growth inhibitors. Reduced expression of these proteins caused by the developmental hypoxia, or direct blockade of the myelin inhibitor pathways in the adult CNS leads to axonal sprouting and the formation of new neuronal connections. The regulation of axonal growth, sprouting and connections in the postnatal brain by myelin proteins is an area of important investigation and potential therapeutic intervention.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15693393     DOI: 10.1053/j.semperi.2004.10.001

Source DB:  PubMed          Journal:  Semin Perinatol        ISSN: 0146-0005            Impact factor:   3.300


  23 in total

1.  Expression of a dominant-negative Rho-kinase promotes neurite outgrowth in a microenvironment mimicking injured central nervous system.

Authors:  Ping Yang; Hui-zhong Wen; Jin-hai Zhang
Journal:  Acta Pharmacol Sin       Date:  2010-04-12       Impact factor: 6.150

Review 2.  Extracellular regulators of axonal growth in the adult central nervous system.

Authors:  Betty P Liu; William B J Cafferty; Stephane O Budel; Stephen M Strittmatter
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2006-09-29       Impact factor: 6.237

3.  Developmental pattern changes of prefrontal efferents in the juvenile gerbil (Meriones unguiculatus).

Authors:  A V Witte; S Brummelte; G Teuchert-Noodt
Journal:  J Neural Transm (Vienna)       Date:  2007-06-08       Impact factor: 3.575

4.  The Nogo receptor NgR1 mediates infection by mammalian reovirus.

Authors:  Jennifer L Konopka-Anstadt; Bernardo A Mainou; Danica M Sutherland; Yuichi Sekine; Stephen M Strittmatter; Terence S Dermody
Journal:  Cell Host Microbe       Date:  2014-06-11       Impact factor: 21.023

Review 5.  Cell replacement therapy in neurological disease.

Authors:  Steven A Goldman; Martha S Windrem
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2006-09-29       Impact factor: 6.237

Review 6.  Sprouting, regeneration and circuit formation in the injured spinal cord: factors and activity.

Authors:  Irin C Maier; Martin E Schwab
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2006-09-29       Impact factor: 6.237

7.  Hypoxia-Induced Upregulation of miR-132 Promotes Schwann Cell Migration After Sciatic Nerve Injury by Targeting PRKAG3.

Authors:  Chun Yao; Xiangxiang Shi; Zhanhu Zhang; Songlin Zhou; Tianmei Qian; Yaxian Wang; Fei Ding; Xiaosong Gu; Bin Yu
Journal:  Mol Neurobiol       Date:  2015-09-23       Impact factor: 5.590

Review 8.  Persistent changes in peripheral and spinal nociceptive processing after early tissue injury.

Authors:  Suellen M Walker; Simon Beggs; Mark L Baccei
Journal:  Exp Neurol       Date:  2015-06-21       Impact factor: 5.330

9.  Targeting a dominant negative rho kinase to neurons promotes axonal outgrowth and partial functional recovery after rat rubrospinal tract lesion.

Authors:  Dongsheng Wu; Ping Yang; Xinyu Zhang; Juan Luo; Mohammed E Haque; John Yeh; Peter M Richardson; Yi Zhang; Xuenong Bo
Journal:  Mol Ther       Date:  2009-07-21       Impact factor: 11.454

10.  Hypoxic injury during neonatal development in murine brain: correlation between in vivo DTI findings and behavioral assessment.

Authors:  Halima Chahboune; Laura R Ment; William B Stewart; Douglas L Rothman; Flora M Vaccarino; Fahmeed Hyder; Michael L Schwartz
Journal:  Cereb Cortex       Date:  2009-04-20       Impact factor: 5.357

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.